The company disclosed preliminary results in mid January, but it left out important metrics such as earnings per share for the fourth quarter.
Eli Lilly will announce Q4 2024 results, with analysts estimating $13.7 billion in sales and $4.94 EPS, alongside a revenue growth outlook for 2024.
Eli Lilly (LLY) is set to announce Q4 earnings results, with analysts expecting positive growth driven by key drugs and new product launches.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback